Lupin reports 52% rise in Q4 consolidated net profit

07 May 2024 Evaluate

Lupin has reported results for fourth quarter (Q4) and year ended March 31, 2024.

The company has reported over 3-fold jump in its net profit at Rs 384.08 crore for the quarter under review as compared to Rs 119.01 crore for the same quarter in the previous year. Total income of the company increased by 18.52% at Rs 3,427.22 crore for Q4FY24 as compared Rs 2,891.57 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 51.91% rise in its net profit at Rs 368.22 crore for fourth quarter ended March 31, 2024 as compared to Rs 242.39 crore for the same quarter in the previous year. Total income of the company increased by 11.70% at Rs 4,990.04 crore for Q4FY24 as compared Rs 4,467.35 crore for the corresponding quarter previous year.

For the year ended March 31, 2024, the company has reported over 5-fold jump in net profit at Rs 2,326.09 crore as compared to Rs 425.21 crore for the previous year. Total income of the company increased by 30.16% at Rs 14,773.23 crore for year under review as compared to Rs 11,350.09 crore for year ended March 31, 2023.

For the year ended March 31, 2024, on the consolidated basis, the company has reported over 4-fold jump in its net profit at Rs 1,935.57 crore as compared to Rs 447.69 crore for the previous year. Total income of the company increased by 20.44% at Rs 20,130.99 crore for year under review as compared to Rs 16,715.02 crore for year ended March 31, 2023.

Lupin Share Price

1661.90 9.40 (0.57%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.